Forasartan
- Level
- Commodity
- Parent
- 51433900
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51433916This classification denotes an angiotensin ii receptor antagonist with the molecular formula C23H28N8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 065F7WPT0B, chemically known as 5-((3,5-dibutyl-1h-1,2,4-triazol-1-yl)methyl)-2-(2-(1h-tetrazol-5-ylphenyl))pyridine but generally known as forasartan, which bears US NIH Compound Identifier 132706. European Medicines Agency schedules Forasartan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07781MIG. The term FORASARTAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 10, No. 3, 1996, List 36). FORASARTAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule forasartan under HS 29333999 and SITC 51574. As of Q4 2014, FORASARTAN remains the US FDA Preferred Term for this commodity. Forasartan bears US NLM identifiers UMLS ID C0250070 and NCI Concept Code C65749. SMILES: n1(nc(nc1CCCC)CCCC)Cc1ccc(nc1)c1c(cccc1)c1n[nH]nn1.
Same parent
Under 51433900 · 37Activities that produce or sell this
KBLI · 8Inherited from family 51430000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.